BioTuesdays

Tag - AVEO

AVEO Pharmaceuticals Logo
Markets

Stifel starts AVEO Pharma at buy; PT $9

Stifel initiated coverage of AVEO Pharmaceuticals (NASDAQ:AVEO) with a “buy” rating and price target of $9. The stock closed at $5.66 on Nov. 6. AVEO is focused on the development and commercialization of targeted...

November 9, 2020
AVEO Pharmaceuticals Logo
Markets

HCW cuts AVEO Pharma PT to $4 from $6

H.C. Wainwright lowered its price target for AVEO Pharmaceuticals (NASDAQ:AVEO) to $4 from $6, but reiterated a “buy” rating, citing discontinuation of the company’s ficlatuzumab program because of COVID-19 and reduced...

April 1, 2020
AVEO Pharmaceuticals Logo
Markets

HCW ups AVEO Pharma to buy; PT to $1.75 from $1

H.C. Wainwright upgraded AVEO Pharmaceuticals (NASDAQ:AVEO) to “buy” from “neutral” and raised its price target to $1.75 from $1, citing a positive overall survival (OS) update from the Phase 3 TIVO-3 study of tivozanib...

September 11, 2019
AVEO Pharmaceuticals Logo
Markets

HCW ups AVEO Pharma PT to $9 from $6.50

H.C. Wainwright raised its price target for AVEO Pharmaceuticals (NASDAQ:AVEO) to $9 from $6.50 after the company reported positive top line results from its Phase 3 TIVO-3 study, evaluating tivozanib for the treatment...

November 6, 2018